prostate cancer
Conditions
Interventions
Index test:A 
system 
for 
early 
diagnosis 
of 
cancer 
based 
on 
several 
biomarkers 
Sponsors
Shanghai Changhai Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Men aged below 85 years. 2. Men with suspected prostate cancer as determined by elevated serum PSA level, positive digital rectum examination, and/or positive findings from imaging examinations, who plan to undergo prostate biopsy to confirm the diagnosis. 3. Men who are well informed of the current diagnosis and treatment options and are willing to participate in this trial.
Exclusion criteria
Exclusion criteria: A patient may not enter the study if ANY of the following applies: 1. Any other previous or current malignancies diagnosed within 5 years; 2. Prior transurethral enucleation or resection of the prostate; 3. Prior history of prostate biopsy for suspected prostate cancer; 4. Metastasis suggested by imaging examination; 5. Sustained use of anticoagulation and antiplatelet drugs; 6. Any other severe systemic diseases; 7. Participation in other trials which are ongoing or have been completed within 12 months; 8. Any contraindications for prostate biopsy; 9. Any other conditions, which, in the judgment of the investigators, are likely to interfere with the assessment or compliance associated with this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| diagnostic performance; | — |
Countries
China
Contacts
Public ContactShancheng Ren
Shanghai Changhai Hospital
Outcome results
None listed